1. Home
  2. OCEA vs SOHO Comparison

OCEA vs SOHO Comparison

Compare OCEA & SOHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCEA
  • SOHO
  • Stock Information
  • Founded
  • OCEA 2019
  • SOHO 2004
  • Country
  • OCEA United States
  • SOHO United States
  • Employees
  • OCEA N/A
  • SOHO N/A
  • Industry
  • OCEA Biotechnology: Pharmaceutical Preparations
  • SOHO Real Estate Investment Trusts
  • Sector
  • OCEA Health Care
  • SOHO Real Estate
  • Exchange
  • OCEA Nasdaq
  • SOHO Nasdaq
  • Market Cap
  • OCEA 20.5M
  • SOHO 21.5M
  • IPO Year
  • OCEA N/A
  • SOHO 2004
  • Fundamental
  • Price
  • OCEA $0.54
  • SOHO $0.88
  • Analyst Decision
  • OCEA
  • SOHO Hold
  • Analyst Count
  • OCEA 0
  • SOHO 1
  • Target Price
  • OCEA N/A
  • SOHO $1.50
  • AVG Volume (30 Days)
  • OCEA 617.7K
  • SOHO 60.6K
  • Earning Date
  • OCEA 01-13-2025
  • SOHO 03-05-2025
  • Dividend Yield
  • OCEA N/A
  • SOHO N/A
  • EPS Growth
  • OCEA N/A
  • SOHO N/A
  • EPS
  • OCEA N/A
  • SOHO N/A
  • Revenue
  • OCEA N/A
  • SOHO $179,860,606.00
  • Revenue This Year
  • OCEA N/A
  • SOHO N/A
  • Revenue Next Year
  • OCEA N/A
  • SOHO $0.70
  • P/E Ratio
  • OCEA N/A
  • SOHO N/A
  • Revenue Growth
  • OCEA N/A
  • SOHO 3.98
  • 52 Week Low
  • OCEA $0.46
  • SOHO $0.85
  • 52 Week High
  • OCEA $7.79
  • SOHO $1.54
  • Technical
  • Relative Strength Index (RSI)
  • OCEA 40.01
  • SOHO 39.34
  • Support Level
  • OCEA $0.53
  • SOHO $0.90
  • Resistance Level
  • OCEA $0.70
  • SOHO $0.93
  • Average True Range (ATR)
  • OCEA 0.08
  • SOHO 0.06
  • MACD
  • OCEA -0.00
  • SOHO -0.00
  • Stochastic Oscillator
  • OCEA 4.31
  • SOHO 20.00

About OCEA Ocean Biomedical Inc.

Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.

About SOHO Sotherly Hotels Inc.

Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.

Share on Social Networks: